Redox-independent activation of NF-kappaB by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line

J Biol Chem. 2008 Oct 3;283(40):27144-53. doi: 10.1074/jbc.M709693200. Epub 2008 Aug 5.

Abstract

The roles of the Pseudomonas aeruginosa-derived pigment pyocyanin (PYO) as an oxidant and activator of the proinflammatory transcription factor NF-kappaB were tested in a cystic fibrosis (CF) airway epithelial cell line, CF15. 100 microm PYO on its own had no effect or only small effects to activate NF-kappaB (<1.5-fold), but PYO synergized with the TLR5 agonist flagellin. Flagellin activated NF-kappaB 4-20-fold, and PYO increased these activations >2.5-fold. PYO could have synergized with flagellin to activate NF-kappaB by redox cycling with NADPH, generating superoxide (O(2)*), hydrogen peroxide (H(2)O(2)), and hydroxyl radical (HO*). Cytosol-targeted, redox-sensitive roGFP1 and imaging microscopy showed that 1-100 microm PYO oxidized CF15 cytosol redox potential (Psi(cyto)) from -325 mV (control) to -285 mV. O(2)* (derived from KO(2)*. or xanthine + xanthine oxidase) or H(2)O(2) oxidized Psi(cyto) dose-dependently but did not activate NF-kappaB, even in the presence of flagellin, and 400 microm H(2)O(2) inhibited NF-kappaB. Overexpressing intracellular catalase decreased effects of PYO and H(2)O(2) on Psi(cyto) but did not affect flagellin + PYO-activated NF-kappaB. Catalase also reversed the inhibitory effects of H(2)O(2) on NF-kappaB. The HO* scavenger DMSO did not alter the effects of PYO on Psi(cyto) and NF-kappaB. The synergistic NF-kappaB activation was calcium-independent. Thus, in the presence of flagellin, PYO activated NF-kappaB through a redox- and calcium-independent effect.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catalase / biosynthesis
  • Catalase / genetics
  • Cell Line
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / metabolism*
  • Cystic Fibrosis / pathology
  • Dimethyl Sulfoxide / pharmacology
  • Drug Synergism
  • Flagellin / agonists
  • Flagellin / pharmacology
  • Free Radical Scavengers / pharmacology
  • Humans
  • Hydrogen Peroxide / metabolism
  • NADP / genetics
  • NADP / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Oxidants / agonists
  • Oxidants / pharmacology*
  • Oxidation-Reduction / drug effects
  • Pseudomonas aeruginosa* / chemistry
  • Pyocyanine / agonists
  • Pyocyanine / chemistry
  • Pyocyanine / pharmacology*
  • Respiratory Mucosa / metabolism*
  • Respiratory Mucosa / pathology
  • Superoxides / metabolism
  • Toll-Like Receptor 5 / agonists
  • Toll-Like Receptor 5 / genetics
  • Toll-Like Receptor 5 / metabolism
  • Xanthine / metabolism
  • Xanthine Oxidase / biosynthesis
  • Xanthine Oxidase / genetics

Substances

  • Free Radical Scavengers
  • NF-kappa B
  • Oxidants
  • TLR5 protein, human
  • Toll-Like Receptor 5
  • Superoxides
  • Flagellin
  • Xanthine
  • NADP
  • Pyocyanine
  • Hydrogen Peroxide
  • Catalase
  • Xanthine Oxidase
  • Dimethyl Sulfoxide